ElixaMD Review
Best for: Shoppers wanting low-cost compounded semaglutide with free dietician and coaching included
ElixaMD is a doctor-guided online weight-loss telehealth offering compounded semaglutide injections from $179 the first month, with free shipping, no membership, no contract, and no insurance required. Plans are all-inclusive — 1:1 physician guidance, free dietician visits and care coaching, 24/7 support, and a patient portal — and HSA/FSA eligible. ElixaMD names its compounding pharmacies (RedRock and Beaker) and publishes a full legal suite. Compounded meds are not FDA-approved (disclosed); $179 is intro pricing, only semaglutide is advertised, and no verifiable LegitScript seal is shown.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
ElixaMD is a solid telehealth option with balanced features and pricing.
ElixaMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide
- Starting price
- $179/mo ('$179 first month' intro/sale, no contract; ongoing/higher-dose tiers ~$249-$299; HSA/FSA eligible)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored ElixaMD
Each dimension is scored algorithmically from ElixaMD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $179/mo, ElixaMD runs about 6% above the $169 median for GLP-1 providers.
Effectiveness25%
8.3/10ElixaMD offers semaglutide, the GLP-1 with the deepest published weight-loss evidence base.
User Experience15%
8.1/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
8.0/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-26).
Accessibility10%
7.2/10ElixaMD's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.6/10ElixaMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this ElixaMD review
Last checked 2026-06-26- Confirmed current pricing across 1 dose/plan tier
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications ElixaMD offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
'$179 first month' intro/sale, no contract; ongoing/higher-dose tiers ~$249-$299; HSA/FSA eligible
Ready to get started?
Plans and promotions change often — check ElixaMD's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide from $179 first month with free shipping, no membership, no contract, and no insurance required
- Genuinely all-inclusive: 1:1 physician guidance, free dietician visits and care coaching, 24/7 support, and an all-in-one patient portal
- Names its compounding pharmacies (RedRock Pharmacy, Beaker Pharmacy) — more transparent than most compounded sellers
- HSA/FSA eligible; full legal suite (Terms, Privacy, Privacy Practices, Refund, Medical Consent, California Bill of Rights)
Watch-outs
- $179 is a first-month/intro price — ongoing monthly cost is higher (tiers to ~$249-$299)
- Compounded semaglutide is not FDA-approved (the site discloses this) — not brand Wegovy or Ozempic
- Appears to offer compounded semaglutide only — tirzepatide is not advertised
- Displays a generic LegitScript Certified badge but no verifiable seal/listing; state-availability list not published
Is ElixaMD worth it? Our verdict
ElixaMD positions itself around one thing: Shoppers wanting low-cost compounded semaglutide with free dietician and coaching included. It runs $179/month.
How much ElixaMD actually costs
- Compounded semaglutide — $179/month
That's roughly in line with the ~$169/month median across the GLP-1 providers we track.
Medications: what ElixaMD prescribes
ElixaMD prescribes semaglutide (the active drug in Wegovy and Ozempic) — one of the most clinically proven GLP-1 options. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who ElixaMD is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
ElixaMD is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
Ready to start with ElixaMD?
Starting at $179/month. See current pricing and start your free consultation.
Alternatives to ElixaMD
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this ElixaMD review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Ready to start with ElixaMD?
Starting at $179/month. See current pricing and start your free consultation.